Cargando…
P38 MAP kinase inhibitors as potential therapeutics for the treatment of joint degeneration and pain associated with osteoarthritis
BACKGROUND: Evaluate the potential role of p38 inhibitors for the treatment of osteoarthritis using an animal model of joint degeneration (iodoacetate-induced arthritis) and a pain model (Hargraeves assay). METHODS: P38 kinase activity was evaluated in a kinase assay by measuring the amount of phosp...
Autores principales: | Brown, Kimberly K, Heitmeyer, Sandra A, Hookfin, Erin B, Hsieh, Lily, Buchalova, Maria, Taiwo, Yetunde O, Janusz, Michael J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612656/ https://www.ncbi.nlm.nih.gov/pubmed/19055838 http://dx.doi.org/10.1186/1476-9255-5-22 |
Ejemplares similares
-
The Role of Inflammasomes in Osteoarthritis and Secondary Joint Degeneration Diseases
por: Roškar, Samo, et al.
Publicado: (2022) -
Differential regulation of anti-inflammatory genes by p38 MAP kinase and MAP kinase kinase 6
por: Hammaker, Deepa, et al.
Publicado: (2014) -
Toll-like receptor 3 activation promotes joint degeneration in osteoarthritis
por: Stolberg-Stolberg, Josef, et al.
Publicado: (2022) -
Differential Modulation of the Phosphoproteome by the MAP Kinases Isoforms p38α and p38β
por: Melamed Kadosh, Dganit, et al.
Publicado: (2023) -
Synthesis and Evaluation of Pyridinyltriazoles as Inhibitors of p38 MAP Kinase
por: Moallem, Seyed Adel, et al.
Publicado: (2012)